Asia Pacific Digital Pathology Market Size & Outlook

Device was the largest segment with a revenue share of 52.18% in 2023. Horizon Databook has segmented the Asia Pacific digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.

The Asia pacific market is anticipated to register highest growth in the digital pathology market owing to factors such as growing awareness of digital pathology and its benefits, rise in personal disposable income, collaborative efforts by health department, and market players encouraging the use of digital pathology to improve the quality of cancer diagnosis in this region.

Asia Pacific region holds the highest mortality rate, followed by North America. According to the American Cancer Society, Inc., in 2018, it was estimated that around 8 million new cases of cancer and around 5 million deaths occurred due to cancer in Southern, Eastern, and South Eastern Asia. Based on a global report by the WHO, a cancer diagnosis is expected to grow by 70% in the next two decades with approximately 1.41 million misdiagnoses of cancer all over the globe.

Regionally, Asia Pacific has highly influenced the digital pathology market due to high incidences of cancer affecting a large population base. Also, increasing demand for novel treatment options, better patient care facilities and reduction in laboratory expenses are further expected to drive the market growth over the coming seven years. The economic development in emerging markets, such as India and China, along with presence of several big medical devices companies in this region drives the demand for digital pathology systems.